SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sal D who wrote (9415)7/17/2005 12:27:47 PM
From: Sergio H  Read Replies (1) of 23958
 
Sal, nice group of stocks.

On IDXC, what do you see? Fundamentals are very strong, insiders are buying, growth is strong but not as strong as previous few years. This may be an issue on the upcoming earnings report. Are you looking at the 10 day MA xover the 50? Look at Sept. - the last time the 10 day xover the 50. IDXC took off on a run from just above $28 to $36.

PHRM I think is the best one you mentioned. Their last earnings report brought up concerns about U.S. sales of Vidaza (for treatment of a disease in which the bone marrow produces dysfunctional blood cells). The company has increased marketing initiatives on the drug and the results of their efforts will be unveiled in the earnings report.

I would be in favor of adding either or both to our folio.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext